Who is good candidate for Ozempic for weight loss?

There is not a certain weight or BMI for you to be a candidate for these medications. Your physician will need to review your medical history and weight loss goals to determine if semaglutide is right for you. Blood work may be needed as well. See your physician or my website to learn more.

Technically a BMI (body mass index) over 30 qualifies for ozempic. Also a BMI over 27 with a related medical condition such as high blood pressure or type 2 diabetes. However since insurance is not covering the cost of these medications in most cases, you could actually have a lower BMI, say 25 or 26, and still be able to use these medications to lose weight. However before going on them, be sure to discuss with your health care provide how you are going to get off these medications- since many people tend to regain some of the weight unless they make key lifestyle changes.

I hope this helps.

Best wishes,
Dr.Bruno

Ozempic is FDA approved as an adjunct to diet and exercise to improve glycemic control in adults with Type 2 Diabetes mellitus, whereas Wegovy is FDA approved for chronic weight management as an adjunct to diet and exercise in patients with BMI > 30, or in patients with BMI > 27 and at least 1 weight-associated comorbidity such as hypertension or dyslipidemia. Thus if you meet these criteria and are trying to lose weight, you may be a good candidate for Wegovy.

Candidates to use these drugs have to have a BMI between 25-30%. But that taking into account all the health problems that are associated with the indiscriminate use of these drugs that become fashionable such as nausea, diarrhea, vomiting, hypoglycemia, thyroid cancer, pancreatitis, it is not worth risking your health unless you are a diabetic patient

Ozempic is primarily used for managing type 2 diabetes, however, it has also been found to be effective for weight loss. As a prescription medication, the decision to use Ozempic for weight loss should always be made in consultation with a healthcare provider.
The U.S. Food and Drug Administration (FDA) has approved semaglutide (brand name Wegovy, which is a higher dose of the same active ingredient in Ozempic) for chronic weight management in adults with obesity or overweight who have at least one weight-related condition, such as high blood pressure, type 2 diabetes, or high cholesterol.
Typically, to qualify for prescription weight-loss medications, individuals must have:
1. A body mass index (BMI) of 30 or higher (which falls into the obesity category), or2. A BMI of 27 or higher (which falls into the overweight category), with at least one weight-related health condition.